Find Technologies
Aryloxypropanoic Acids-Based Mitochondrially Targeted Prodrugs. I. Phenol and Pyridinol-Based Antioxidants
Technology ID:
6-1390
Applications:
With 6-1250 and 6-1467, this suite of technologies describes therapeutic approaches to diseases such as neurodegeneration, stroke, ischemia/reperfusion, diabetes, cardiomyopathy, and cancer that involved targeting the mitochondria. More specifically, these technologies describe the synthesis of mitochondrial targeted antioxidant compounds that will reduce ROS production and damage which underlies or contributes to the progression of disease.
Intellectual Property Status:
US Patent Number issued 01/01/1899
Inventors:
Marion Anders
For Additional Information or for Licensing Opportunities:
Matan Rapoport, Ph.D.
Licensing Associate
Office of Technology Transfer
585.276.6607
Licensing Associate
Office of Technology Transfer
585.276.6607
Category:
Therapeutic:Metabolic
Keywords:
Mitochondria
Discover the Future
Stay Informed
Subscribe to the Technology Transfer RSS feed, and be notified when new topics are added to our Technology listings.
